Literature DB >> 17174561

Mediation of aldose reductase in lipopolysaccharide-induced inflammatory signals in mouse peritoneal macrophages.

Kota V Ramana1, Satish K Srivastava.   

Abstract

Aldose reductase (AR; AKR1B1) a member of aldo-keto reductase super family, that we had shown earlier mediates cytotoxic signals induced by high glucose, cytokines and growth factors, also mediates the inflammatory signals induced by Gram-negative bacterial endotoxin, lipopolysaccharide (LPS). Inhibition of AR by three distinct AR inhibitors sorbinil, tolrestat or zopolrestat suppressed the LPS-induced production of inflammatory cytokines such as TNF-alpha, IL-6, IL-1beta, IFN-gamma, and chemokine MCP-1 in murine peritoneal macrophages. Inhibition of AR also prevented the production of nitric oxide, and prostaglandin E2 and expression of iNOS and Cox-2 proteins. The LPS-induced DNA binding activity of NF-kappaB and AP1 were significantly inhibited by AR inhibitors, and this effect was mediated through the inhibition of phosphorylation of IkappaB-alpha, IKK alpha/beta and PKC. These results suggest the therapeutic use of AR inhibitors as anti-inflammatory drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17174561      PMCID: PMC1850149          DOI: 10.1016/j.cyto.2006.11.003

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  34 in total

1.  Down-regulatory effect of quercitrin gallate on nuclear factor-kappa B-dependent inducible nitric oxide synthase expression in lipopolysaccharide-stimulated macrophages RAW 264.7.

Authors:  Byung Hak Kim; Sung Min Cho; Alavala Matta Reddy; Yeong Shik Kim; Kyung Rak Min; Youngsoo Kim
Journal:  Biochem Pharmacol       Date:  2005-04-14       Impact factor: 5.858

2.  Macrophages in innate and acquired immunity.

Authors:  Homer L Twigg
Journal:  Semin Respir Crit Care Med       Date:  2004-02       Impact factor: 3.119

Review 3.  Epidemiology of severe sepsis around the world.

Authors:  Derek C Angus; Carlos Alberto Pires Pereira; Eliezer Silva
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2006-06       Impact factor: 2.895

Review 4.  Cytokines, PGE2 and endotoxic fever: a re-assessment.

Authors:  Clark M Blatteis; Shuxin Li; Zhonghua Li; Carlos Feleder; Vit Perlik
Journal:  Prostaglandins Other Lipid Mediat       Date:  2005-02-19       Impact factor: 3.072

5.  Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells.

Authors:  Sanjay Srivastava; Kota V Ramana; Ravinder Tammali; Satish K Srivastava; Aruni Bhatnagar
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

6.  Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase.

Authors:  Kota V Ramana; Brian Friedrich; Sanjay Srivastava; Aruni Bhatnagar; Satish K Srivastava
Journal:  Diabetes       Date:  2004-11       Impact factor: 9.461

7.  Enhanced expression of cyclooxygenase-2 and prostaglandin E2 in response to endotoxin after trauma is dependent on MAPK and NF-kappaB mechanisms.

Authors:  Zhaoping Yan; Philip P Stapleton; Tracy A Freeman; Michele Fuortes; John M Daly
Journal:  Cell Immunol       Date:  2004 Nov-Dec       Impact factor: 4.868

8.  Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B.

Authors:  Hye Sun Park; Hye Young Jung; Eun Young Park; Jaesang Kim; Won Jae Lee; Yun Soo Bae
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

Review 9.  Initial responses to endotoxins and Gram-negative bacteria.

Authors:  Didier Heumann; Thierry Roger
Journal:  Clin Chim Acta       Date:  2002-09       Impact factor: 3.786

10.  Inducible nitric oxide synthase and apoptosis in murine proximal tubule epithelial cells.

Authors:  Manish M Tiwari; Kurt J Messer; Philip R Mayeux
Journal:  Toxicol Sci       Date:  2006-03-21       Impact factor: 4.849

View more
  32 in total

1.  Aldose reductase inhibition prevents lipopolysaccharide-induced glucose uptake and glucose transporter 3 expression in RAW264.7 macrophages.

Authors:  Aramati B M Reddy; Satish K Srivastava; Kota V Ramana
Journal:  Int J Biochem Cell Biol       Date:  2010-03-27       Impact factor: 5.085

Review 2.  A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases.

Authors:  Saumya Pandey; Satish K Srivastava; Kota V Ramana
Journal:  Expert Opin Investig Drugs       Date:  2012-01-28       Impact factor: 6.206

3.  Anti-inflammatory effects of benfotiamine are mediated through the regulation of the arachidonic acid pathway in macrophages.

Authors:  Mohammad Shoeb; Kota V Ramana
Journal:  Free Radic Biol Med       Date:  2011-10-24       Impact factor: 7.376

Review 4.  AKR1B1 Upregulation Contributes to Neuroinflammation and Astrocytes Proliferation by Regulating the Energy Metabolism in Rat Spinal Cord Injury.

Authors:  Xiaoqing Chen; Cheng Chen; Jie Hao; Rongqing Qin; Baiyu Qian; Kai Yang; Jiyun Zhang; Feng Zhang
Journal:  Neurochem Res       Date:  2018-06-12       Impact factor: 3.996

5.  Protective role of benfotiamine, a fat-soluble vitamin B1 analogue, in lipopolysaccharide-induced cytotoxic signals in murine macrophages.

Authors:  Umesh C S Yadav; Nilesh M Kalariya; Satish K Srivastava; Kota V Ramana
Journal:  Free Radic Biol Med       Date:  2010-02-26       Impact factor: 7.376

6.  Aldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microglia.

Authors:  Kun-Che Chang; Jessica Ponder; Daniel V Labarbera; J Mark Petrash
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-02       Impact factor: 4.799

7.  Anti-inflammatory effect of aldose reductase inhibition in murine polymicrobial sepsis.

Authors:  Aramati B M Reddy; Satish K Srivastava; Kota V Ramana
Journal:  Cytokine       Date:  2009-08-05       Impact factor: 3.861

8.  Upregulation of aldose reductase during foam cell formation as possible link among diabetes, hyperlipidemia, and atherosclerosis.

Authors:  Christian A Gleissner; John M Sanders; Jerry Nadler; Klaus Ley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-01       Impact factor: 8.311

9.  Beta-glucogallin reduces the expression of lipopolysaccharide-induced inflammatory markers by inhibition of aldose reductase in murine macrophages and ocular tissues.

Authors:  Kun-Che Chang; Brian Laffin; Jessica Ponder; Anna Enzsöly; János Németh; Daniel V LaBarbera; J Mark Petrash
Journal:  Chem Biol Interact       Date:  2012-12-15       Impact factor: 5.192

10.  Identification of regulatory Hck and PAI-2 proteins in the monocyte response to PEG-containing matrices.

Authors:  Sean T Zuckerman; James F Brown; Weiyuan J Kao
Journal:  Biomaterials       Date:  2009-05-14       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.